OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch, Hermela Shimelis, Chunling Hu, et al.
JAMA Oncology (2017) Vol. 3, Iss. 9, pp. 1190-1190
Open Access | Times Cited: 546

Showing 1-25 of 546 citing articles:

Breast cancer
Nadia Harbeck, Frédérique Penault‐Llorca, Javier Cortés, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 2235

A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu, Steven N. Hart, Rohan Gnanaolivu, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 5, pp. 440-451
Open Access | Times Cited: 612

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
Alicia Latham, Preethi Srinivasan, Yelena Kemel, et al.
Journal of Clinical Oncology (2018) Vol. 37, Iss. 4, pp. 286-295
Open Access | Times Cited: 504

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu, Steven N. Hart, Eric C. Polley, et al.
JAMA (2018) Vol. 319, Iss. 23, pp. 2401-2401
Open Access | Times Cited: 492

Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Dharambir Kashyap, Deeksha Pal, Riya Sharma, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 399

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Allison W. Kurian, Kevin C. Ward, Nadia Howlader, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 15, pp. 1305-1315
Open Access | Times Cited: 315

Contrast‐enhanced MRI for breast cancer screening
Ritse M. Mann, Christiane Kühl, Linda Moy
Journal of Magnetic Resonance Imaging (2019) Vol. 50, Iss. 2, pp. 377-390
Open Access | Times Cited: 281

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Hermela Shimelis, Holly LaDuca, Chunling Hu, et al.
JNCI Journal of the National Cancer Institute (2018) Vol. 110, Iss. 8, pp. 855-862
Open Access | Times Cited: 255

MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
Lei Bian, Yiling Meng, Meichao Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 187

Breast cancer in adolescents and young adults
Rebecca H. Johnson, Carey K. Anders, Jennifer K. Litton, et al.
Pediatric Blood & Cancer (2018) Vol. 65, Iss. 12
Open Access | Times Cited: 183

CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Lenka Stolařová, Petra Kleiblová, Markéta Janatová, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2675-2675
Open Access | Times Cited: 154

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
Pascal Pujol, Massimo Barberis, Philp Beer, et al.
European Journal of Cancer (2021) Vol. 146, pp. 30-47
Open Access | Times Cited: 147

Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers
Michael J. Hall, Ryan Bernhisel, Elisha Hughes, et al.
Cancer Prevention Research (2021) Vol. 14, Iss. 4, pp. 433-440
Open Access | Times Cited: 116

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Isabelle Bedrosian, Mark R. Somerfield, Maria Isabel Achatz, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 5, pp. 584-604
Closed Access | Times Cited: 68

EXO1 protects BRCA1-deficient cells against toxic DNA lesions
Bert van de Kooij, Anne Schreuder, Raphael Pavani, et al.
Molecular Cell (2024) Vol. 84, Iss. 4, pp. 659-674.e7
Open Access | Times Cited: 15

Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing
Hsiao‐Mei Lu, Shuwei Li, Mary Helen Black, et al.
JAMA Oncology (2018) Vol. 5, Iss. 1, pp. 51-51
Open Access | Times Cited: 152

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
Jenna Lilyquist, Holly LaDuca, Eric C. Polley, et al.
Gynecologic Oncology (2017) Vol. 147, Iss. 2, pp. 375-380
Open Access | Times Cited: 143

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Thomas P. Slavin, Kara N. Maxwell, Jenna Lilyquist, et al.
npj Breast Cancer (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 120

RAD-ical New Insights into RAD51 Regulation
Meghan R. Sullivan, Kara A. Bernstein
Genes (2018) Vol. 9, Iss. 12, pp. 629-629
Open Access | Times Cited: 118

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer
Nana Weber‐Lassalle, Jan Hauke, Juliane Ramser, et al.
Breast Cancer Research (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 113

Cancer genetics, precision prevention and a call to action
Clare Turnbull, Amit Sud, Richard S. Houlston
Nature Genetics (2018) Vol. 50, Iss. 9, pp. 1212-1218
Open Access | Times Cited: 113

A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function
Lea M. Starita, Muhtadi M. Islam, Tapahsama Banerjee, et al.
The American Journal of Human Genetics (2018) Vol. 103, Iss. 4, pp. 498-508
Open Access | Times Cited: 104

Page 1 - Next Page

Scroll to top